{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:06:11Z","timestamp":1793505971044,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schizophr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The \u201cdopamine hypothesis\u201d of schizophrenia suggests the imbalance of the brain dopamine system plays a crucial role in the development of this disorder. Although this hypothesis has been partly supported by early studies, the brain region-specific abnormalities of different dopamine subsystems, and the influential factors on the heterogeneity of dopamine dysfunction of schizophrenia are still unknown. To address these issues, we carried out random-effect meta-analyses by collecting 49 in vivo PET studies (692 patients and 730 controls). Patients exhibited significant regional and population heterogeneity in D\n                    <jats:sub>2\/3<\/jats:sub>\n                    receptor availability, primarily manifesting as a moderate increased in the striatum of only drug-off patients (Cohen\u2019s d\u2009=\u20090.56, 95%CI [0.16; 0.97]), whereas only drug-on patients showed a large decrease in D\n                    <jats:sub>2\/3<\/jats:sub>\n                    receptor availability in the thalamus, limbic lobe, substantia nigra, and temporal lobe (Cohen\u2019s d\u2009&lt;\u2009\u22121.40). Drug-off patients also had a small increase in dopamine synthesis in the striatum (Cohen\u2019s d\u2009=\u20090.38, 95%CI[0.06; 0.69]), with no replicable dysfunctions in drug-on patients or other brain regions. D\n                    <jats:sub>1<\/jats:sub>\n                    receptor availability and DAT showed high heterogeneity but no consistent significances. Finally, Meta-regression indicated that elevated striatal D\n                    <jats:sub>2\/3<\/jats:sub>\n                    levels correlated with a higher proportion of males, older patients, longer duration and worse symptoms predicted more severe D\n                    <jats:sub>1<\/jats:sub>\n                    deficits in the striatum and prefrontal cortex. This study suggests that different dopamine subsystems in schizophrenia are selectively involved across brain regions; moreover, medication status, sex, age, illness duration and symptom diversity have significant impacts on the dysfunctions of dopamine subsystems in schizophrenia.\n                  <\/jats:p>","DOI":"10.1038\/s41537-025-00684-0","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:49:56Z","timestamp":1763729396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Resolving the heterogeneity of dopamine subsystems dysfunction in schizophrenia: a PET meta-analysis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3508-143X","authenticated-orcid":false,"given":"Zhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3965-4639","authenticated-orcid":false,"given":"Haoyang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5648-5199","authenticated-orcid":false,"given":"Chunshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-520X","authenticated-orcid":false,"given":"Meng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-8296","authenticated-orcid":false,"given":"Wen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","volume":"2","author":"HY Meltzer","year":"1976","unstructured":"Meltzer, H. Y. & Stahl, S. M. The dopamine hypothesis of schizophrenia: a review. Schizophr. Bull. 2, 19\u201376 (1976).","journal-title":"Schizophr. Bull."},{"key":"684_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","volume":"81","author":"OD Howes","year":"2017","unstructured":"Howes, O. D., McCutcheon, R., Owen, M. J. & Murray, R. M. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia. Biol. Psychiatry 81, 9\u201320 (2017).","journal-title":"Biol. Psychiatry"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5498\/wjp.v11.i7.355","volume":"11","author":"MV Seeman","year":"2021","unstructured":"Seeman, M. V. History of the dopamine hypothesis of antipsychotic action. World J. Psychiatry 11, 355\u2013364 (2021).","journal-title":"World J. Psychiatry"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0031-6997(25)06839-5","volume":"32","author":"P Seeman","year":"1980","unstructured":"Seeman, P. Brain dopamine receptors. Pharm. Rev. 32, 229\u2013313 (1980).","journal-title":"Pharm. Rev."},{"key":"684_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamapsychiatry.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein, M. et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72, 316\u2013324 (2015).","journal-title":"JAMA Psychiatry"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1093\/cercor\/bhad096","volume":"33","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Structural covariances of prefrontal subregions selectively associate with dopamine-related gene coexpression and schizophrenia. Cereb. Cortex 33, 8035\u20138045 (2023).","journal-title":"Cereb. Cortex"},{"key":"684_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wps.20693","volume":"19","author":"RA McCutcheon","year":"2020","unstructured":"McCutcheon, R. A., Krystal, J. H. & Howes, O. D. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 19, 15\u201333 (2020).","journal-title":"World Psychiatry"},{"key":"684_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee, C. S. et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc. 47, 493\u2013503 (2000).","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"684_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner, S. C., Le, T. & Wang, S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem Biophys. 508, 1\u201312 (2011).","journal-title":"Arch. Biochem Biophys."},{"key":"684_CR10","unstructured":"Bhatia, A., Lenchner, J. R. & Saadabadi, A. in StatPearls (StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC., 2025)."},{"key":"684_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","volume":"632","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. Nature 632, 686\u2013694 (2024).","journal-title":"Nature"},{"key":"684_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02233-0","volume":"12","author":"H Xu","year":"2022","unstructured":"Xu, H. & Yang, F. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl. Psychiatry 12, 464 (2022).","journal-title":"Transl. Psychiatry"},{"key":"684_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace, A. A. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat. Rev. Neurosci. 17, 524\u2013532 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"684_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archpsyc.1982.04290090001001","volume":"39","author":"AV Mackay","year":"1982","unstructured":"Mackay, A. V. et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch. Gen. Psychiatry 39, 991\u2013997 (1982).","journal-title":"Arch. Gen. Psychiatry"},{"key":"684_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1176\/ajp.137.2.191","volume":"137","author":"T Lee","year":"1980","unstructured":"Lee, T. & Seeman, P. Elevation of brain neuroleptic\/dopamine receptors in schizophrenia. Am. J. Psychiatry 137, 191\u2013197 (1980).","journal-title":"Am. J. Psychiatry"},{"key":"684_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/brain\/102.2.347","volume":"102","author":"ED Bird","year":"1979","unstructured":"Bird, E. D., Spokes, E. G. & Iversen, L. L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 102, 347\u2013360 (1979).","journal-title":"Brain"},{"key":"684_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1749-6632.1988.tb42115.x","volume":"537","author":"E Widerl\u00f6v","year":"1988","unstructured":"Widerl\u00f6v, E. A critical appraisal of CSF monoamine metabolite studies in schizophrenia. Ann. N. Y. Acad. Sci. 537, 309\u2013323 (1988).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"684_CR18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis, K. L., Kahn, R. S., Ko, G. & Davidson, M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148, 1474\u20131486 (1991).","journal-title":"Am. J. Psychiatry"},{"key":"684_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/schbul\/sbp010","volume":"37","author":"GJ Lyon","year":"2011","unstructured":"Lyon, G. J. et al. Presynaptic regulation of dopamine transmission in schizophrenia. Schizophrenia Bull. 37, 108\u2013117 (2011).","journal-title":"Schizophrenia Bull."},{"key":"684_CR20","doi-asserted-by":"publisher","unstructured":"Tan, J. et al. Progress in the application of molecular imaging in psychiatric disorders. Psychoradiology https:\/\/doi.org\/10.1093\/psyrad\/kkad020 (2023).","DOI":"10.1093\/psyrad\/kkad020"},{"key":"684_CR21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00259-013-2606-5","volume":"41","author":"BF Hutton","year":"2014","unstructured":"Hutton, B. F. The origins of SPECT and SPECT\/CT. Eur. J. Nucl. Med. Mol. Imaging 41, S3\u2013S16 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"684_CR22","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2174\/092986706777935258","volume":"13","author":"PH Elsinga","year":"2006","unstructured":"Elsinga, P. H., Hatano, K. & Ishiwata, K. PET tracers for imaging of the dopaminergic system. Curr. Med Chem. 13, 2139\u20132153 (2006).","journal-title":"Curr. Med Chem."},{"key":"684_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon, R. A., Abi-Dargham, A. & Howes, O. D. Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci. 42, 205\u2013220 (2019).","journal-title":"Trends Neurosci."},{"key":"684_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.biopsych.2017.11.032","volume":"83","author":"WG Frankle","year":"2018","unstructured":"Frankle, W. G. et al. Amphetamine-induced striatal dopamine release measured with an agonist radiotracer in schizophrenia. Biol. Psychiatry 83, 707\u2013714 (2018).","journal-title":"Biol. Psychiatry"},{"key":"684_CR25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/npp.2008.199","volume":"34","author":"A Graff-Guerrero","year":"2009","unstructured":"Graff-Guerrero, A. et al. The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study. Neuropsychopharmacology 34, 1078\u20131086 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"684_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/385634a0","volume":"385","author":"Y Okubo","year":"1997","unstructured":"Okubo, Y. et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385, 634\u2013636 (1997).","journal-title":"Nature"},{"key":"684_CR27","first-page":"166","volume":"2","author":"A Abi-Dargham","year":"2003","unstructured":"Abi-Dargham, A. Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?. World Psychiatry 2, 166\u2013171 (2003).","journal-title":"World Psychiatry"},{"key":"684_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/appi.ajp.159.5.761","volume":"159","author":"P Karlsson","year":"2002","unstructured":"Karlsson, P., Farde, L., Halldin, C. & Sedvall, G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am. J. Psychiatry 159, 761\u2013767 (2002).","journal-title":"Am. J. Psychiatry"},{"key":"684_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","volume":"74","author":"S Jauhar","year":"2017","unstructured":"Jauhar, S. et al. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia. JAMA psychiatry 74, 1206\u20131213 (2017).","journal-title":"JAMA psychiatry"},{"key":"684_CR30","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/awz093","volume":"142","author":"M Avram","year":"2019","unstructured":"Avram, M. et al. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain 142, 1813\u20131826 (2019).","journal-title":"Brain"},{"key":"684_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00008877-200109000-00007","volume":"12","author":"LP Kestler","year":"2001","unstructured":"Kestler, L. P., Walker, E. & Vega, E. M. Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behav. Pharm. 12, 355\u2013371 (2001).","journal-title":"Behav. Pharm."},{"key":"684_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.schres.2012.06.027","volume":"140","author":"Z Yilmaz","year":"2012","unstructured":"Yilmaz, Z. et al. Antipsychotics, dopamine D(2) receptor occupancy and clinical improvement in schizophrenia: a meta-analysis. Schizophr. Res 140, 214\u2013220 (2012).","journal-title":"Schizophr. Res"},{"key":"684_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/schbul\/sbr111","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli, P. & Meyer-Lindenberg, A. Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr. Bull. 39, 22\u201332 (2013).","journal-title":"Schizophr. Bull."},{"key":"684_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/schbul\/sbr180","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli, P. & Meyer-Lindenberg, A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F\/(11)C]-DOPA PET studies. Schizophr. Bull. 39, 33\u201342 (2013).","journal-title":"Schizophr. Bull."},{"key":"684_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/JCP.0b013e3182983ffa","volume":"33","author":"IM Lako","year":"2013","unstructured":"Lako, I. M., van den Heuvel, E. R., Knegtering, H., Bruggeman, R. & Taxis, K. Estimating dopamine D(2) receptor occupancy for doses of 8 antipsychotics: a meta-analysis. J. Clin. Psychopharmacol. 33, 675\u2013681 (2013).","journal-title":"J. Clin. Psychopharmacol."},{"key":"684_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/schbul\/sbx180","volume":"44","author":"R McCutcheon","year":"2018","unstructured":"McCutcheon, R., Beck, K., Jauhar, S. & Howes, O. D. Defining the locus of dopaminergic dysfunction in schizophrenia: a meta-analysis and test of the mesolimbic hypothesis. Schizophr. Bull. 44, 1301\u20131311 (2018).","journal-title":"Schizophr. Bull."},{"key":"684_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2019.07.008","volume":"87","author":"SP Brugger","year":"2020","unstructured":"Brugger, S. P. et al. Heterogeneity of striatal dopamine function in schizophrenia: meta-analysis of variance. Biol. Psychiatry 87, 215\u2013224 (2020).","journal-title":"Biol. Psychiatry"},{"key":"684_CR38","doi-asserted-by":"publisher","first-page":"107591","DOI":"10.1016\/j.neuropharm.2019.03.034","volume":"163","author":"F Caravaggio","year":"2020","unstructured":"Caravaggio, F. et al. What proportion of striatal D2 receptors are occupied by endogenous dopamine at baseline? A meta-analysis with implications for understanding antipsychotic occupancy. Neuropharmacology 163, 107591 (2020).","journal-title":"Neuropharmacology"},{"key":"684_CR39","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41380-021-01349-x","volume":"27","author":"P Plaven-Sigray","year":"2022","unstructured":"Plaven-Sigray, P. et al. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis. Mol. Psychiatry 27, 1233\u20131240 (2022).","journal-title":"Mol. Psychiatry"},{"key":"684_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/schbul\/sbn009","volume":"35","author":"JM Stone","year":"2009","unstructured":"Stone, J. M., Davis, J. M., Leucht, S. & Pilowsky, L. S. Cortical dopamine D2\/D3 receptors are a common site of action for antipsychotic drugs-an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature. Schizophr. Bull. 35, 789\u2013797 (2009).","journal-title":"Schizophr. Bull."},{"key":"684_CR41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes, O. D. et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch. Gen. Psychiatry 69, 776\u2013786 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"684_CR42","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1192\/bjp.bp.113.132308","volume":"204","author":"J Kambeitz","year":"2014","unstructured":"Kambeitz, J., Abi-Dargham, A., Kapur, S. & Howes, O. D. Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies. Br. J. Psychiatry 204, 420\u2013429 (2014).","journal-title":"Br. J. Psychiatry"},{"key":"684_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0925-4927(96)02728-X","volume":"67","author":"T Larry","year":"1996","unstructured":"Larry, T. et al. Striatal dopamine D2 receptor quantification and superior temporal gyrus: Volume determination in 14 chronic schizophrenic subjects. Psychiatry Res.: Neuroimaging 67, 155\u2013158 (1996).","journal-title":"Psychiatry Res.: Neuroimaging"},{"key":"684_CR44","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awt264","volume":"136","author":"OD Howes","year":"2013","unstructured":"Howes, O. D. et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain 136, 3242\u20133251 (2013).","journal-title":"Brain"},{"key":"684_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.pscychresns.2004.04.005","volume":"138","author":"Y Fumihiko","year":"2005","unstructured":"Fumihiko, Y. et al. Abnormal effective connectivity of dopamine D2 receptor binding in schizophrenia. Psychiatry Res.: Neuroimaging 138, 197\u2013207 (2005).","journal-title":"Psychiatry Res.: Neuroimaging"},{"key":"684_CR46","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/brain\/awaa296","volume":"143","author":"M Avram","year":"2020","unstructured":"Avram, M. et al. Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia. Brain 143, 3495\u20133505 (2020).","journal-title":"Brain"},{"key":"684_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00213-013-3026-8","volume":"228","author":"EM Poels","year":"2013","unstructured":"Poels, E. M., Girgis, R. R., Thompson, J. L., Slifstein, M. & Abi-Dargham, A. In vivo binding of the dopamine-1 receptor PET tracers [\u00b9\u00b9C]NNC112 and [\u00b9\u00b9C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacol. ((Berl.)) 228, 167\u2013174 (2013).","journal-title":"Psychopharmacol. ((Berl.))"},{"key":"684_CR48","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","volume":"75","author":"A Demjaha","year":"2014","unstructured":"Demjaha, A. et al. Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. Biol. Psychiatry 75, e11\u2013e13 (2014).","journal-title":"Biol. Psychiatry"},{"key":"684_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archpsyc.59.1.25","volume":"59","author":"T Suhara","year":"2002","unstructured":"Suhara, T. et al. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch. Gen. Psychiatry 59, 25\u201330 (2002).","journal-title":"Arch. Gen. Psychiatry"},{"key":"684_CR50","doi-asserted-by":"crossref","unstructured":"Nozaki, S. et al. Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET. Schizophr. Res 108, 78\u201384 (2009)..","DOI":"10.1016\/j.schres.2008.11.006"},{"key":"684_CR51","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1523\/JNEUROSCI.0805-07.2007","volume":"27","author":"Y Kumakura","year":"2007","unstructured":"Kumakura, Y. et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa\/positron emission tomography study. J. Neurosci. 27, 8080\u20138087 (2007).","journal-title":"J. Neurosci."},{"key":"684_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4927(00)00064-0","volume":"100","author":"AM Elkashef","year":"2000","unstructured":"Elkashef, A. M. et al. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Psychiatry Res 100, 1\u201311 (2000).","journal-title":"Psychiatry Res"},{"key":"684_CR53","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.lfs.2010.03.018","volume":"86","author":"J Kosaka","year":"2010","unstructured":"Kosaka, J. et al. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia. Life Sci. 86, 814\u2013818 (2010).","journal-title":"Life Sci."},{"key":"684_CR54","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jpsychires.2009.04.009","volume":"43","author":"R Arakawa","year":"2009","unstructured":"Arakawa, R. et al. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. J. Psychiatr. Res 43, 1219\u20131223 (2009).","journal-title":"J. Psychiatr. Res"},{"key":"684_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/schbul\/sbw192","volume":"43","author":"E Artiges","year":"2017","unstructured":"Artiges, E. et al. Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study. Schizophr. Bull. 43, 1134\u20131142 (2017).","journal-title":"Schizophr. Bull."},{"key":"684_CR56","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/npp.2017.180","volume":"43","author":"AS Berry","year":"2018","unstructured":"Berry, A. S. et al. Dopamine Synthesis Capacity is Associated with D2\/3 Receptor Binding but Not Dopamine Release. Neuropsychopharmacology 43, 1201\u20131211 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"684_CR57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/sj.npp.1300931","volume":"31","author":"G Grunder","year":"2006","unstructured":"Grunder, G. et al. The striatal and extrastriatal D2\/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31, 1027\u20131035 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"684_CR58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00406-017-0821-y","volume":"268","author":"YH Joo","year":"2018","unstructured":"Joo, Y. H. et al. The relationship between excitement symptom severity and extrastriatal dopamine D(2\/3) receptor availability in patients with schizophrenia: a high-resolution PET study with [(18)F]fallypride. Eur. Arch. Psychiatry Clin. Neurosci. 268, 529\u2013540 (2018).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"684_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0925-4927(95)02732-D","volume":"61","author":"AL Nordstrom","year":"1995","unstructured":"Nordstrom, A. L., Farde, L., Eriksson, L. & Halldin, C. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone. Psychiatry Res 61, 67\u201383 (1995).","journal-title":"Psychiatry Res"},{"key":"684_CR60","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/archgenpsychiatry.2009.43","volume":"66","author":"A Graff-Guerrero","year":"2009","unstructured":"Graff-Guerrero, A. et al. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. Arch. Gen. Psychiatry 66, 606\u2013615 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"684_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1755-5949.2010.00222.x","volume":"17","author":"M Nord","year":"2011","unstructured":"Nord, M. & Farde, L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci. Ther. 17, 97\u2013103 (2011).","journal-title":"CNS Neurosci. Ther."},{"key":"684_CR62","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle, M. et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. USA 93, 9235\u20139240 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"684_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","volume":"67","author":"LS Kegeles","year":"2010","unstructured":"Kegeles, L. S. et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch. Gen. Psychiatry 67, 231\u2013239 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"684_CR64","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/syn.20265","volume":"59","author":"HA Erdely","year":"2006","unstructured":"Erdely, H. A., Tamminga, C. A., Roberts, R. C. & Vogel, M. W. Regional alterations in RGS4 protein in schizophrenia. Synapse 59, 472\u2013479 (2006).","journal-title":"Synapse"},{"key":"684_CR65","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/(SICI)1098-2396(199607)23:3<232::AID-SYN13>3.0.CO;2-0","volume":"23","author":"W Wang","year":"1996","unstructured":"Wang, W. et al. Up-regulation of D3 dopamine receptor mRNA by neuroleptics. Synapse 23, 232\u2013235 (1996).","journal-title":"Synapse"},{"key":"684_CR66","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41591-020-0793-8","volume":"26","author":"A Li","year":"2020","unstructured":"Li, A. et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat. Med 26, 558\u2013565 (2020).","journal-title":"Nat. Med"},{"key":"684_CR67","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","volume":"52","author":"A Laakso","year":"2001","unstructured":"Laakso, A. et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr. Res 52, 115\u2013120 (2001).","journal-title":"Schizophr. Res"},{"key":"684_CR68","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.biopsych.2018.09.010","volume":"85","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon, R. A. et al. Mesolimbic Dopamine Function Is Related to Salience Network Connectivity: An Integrative Positron Emission Tomography and Magnetic Resonance Study. Biol. Psychiatry 85, 368\u2013378 (2019).","journal-title":"Biol. Psychiatry"},{"key":"684_CR69","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2018.11.044","volume":"1713","author":"CMV Weele","year":"2019","unstructured":"Weele, C. M. V., Siciliano, C. A. & Tye, K. M. Dopamine tunes prefrontal outputs to orchestrate aversive processing. Brain Res 1713, 16\u201331 (2019).","journal-title":"Brain Res"},{"key":"684_CR70","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/schbul\/13.4.589","volume":"13","author":"AF Oke","year":"1987","unstructured":"Oke, A. F. & Adams, R. N. Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia. Schizophr. Bull. 13, 589\u2013604 (1987).","journal-title":"Schizophr. Bull."},{"key":"684_CR71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1751-7893.2012.00387.x","volume":"7","author":"Z Wang","year":"2013","unstructured":"Wang, Z. et al. Comparison of first-episode and chronic patients diagnosed with schizophrenia: symptoms and childhood trauma. Early Inter. Psychiatry 7, 23\u201330 (2013).","journal-title":"Early Inter. Psychiatry"},{"key":"684_CR72","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1002\/hbm.25108","volume":"41","author":"Y Alem\u00e1n-G\u00f3mez","year":"2020","unstructured":"Alem\u00e1n-G\u00f3mez, Y. et al. Partial-volume modeling reveals reduced gray matter in specific thalamic nuclei early in the time course of psychosis and chronic schizophrenia. Hum. Brain Mapp. 41, 4041\u20134061 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"684_CR73","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41537-022-00323-y","volume":"8","author":"ZB Millman","year":"2022","unstructured":"Millman, Z. B. et al. Auditory hallucinations, childhood sexual abuse, and limbic gray matter volume in a transdiagnostic sample of people with psychosis. Schizophrenia ((Heidelb.)) 8, 118 (2022).","journal-title":"Schizophrenia ((Heidelb.))"},{"key":"684_CR74","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1002\/hbm.20807","volume":"30","author":"DI Kim","year":"2009","unstructured":"Kim, D. I. et al. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum. Brain Mapp. 30, 3795\u20133811 (2009).","journal-title":"Hum. Brain Mapp."},{"key":"684_CR75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1192\/bjp.181.4.271","volume":"181","author":"HM Jones","year":"2002","unstructured":"Jones, H. M. & Pilowsky, L. S. Dopamine and antipsychotic drug action revisited. Br. J. Psychiatry 181, 271\u2013275 (2002).","journal-title":"Br. J. Psychiatry"},{"key":"684_CR76","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/syn.20053","volume":"53","author":"P Rosa-Neto","year":"2004","unstructured":"Rosa-Neto, P. et al. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain. Synapse 53, 222\u2013233 (2004).","journal-title":"Synapse"},{"key":"684_CR77","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1007\/s00259-014-2708-8","volume":"41","author":"M Tian","year":"2014","unstructured":"Tian, M. et al. PET imaging reveals brain functional changes in internet gaming disorder. Eur. J. Nucl. Med Mol. Imaging 41, 1388\u20131397 (2014).","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"684_CR78","unstructured":"Leung, K. in Molecular Imaging and Contrast Agent Database (MICAD) (National Center for Biotechnology Information (US), 2004)."},{"key":"684_CR79","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/00006231-200111000-00008","volume":"22","author":"Y Sudo","year":"2001","unstructured":"Sudo, Y. et al. Reproducibility of [11C] FLB 457 binding in extrastriatal regions. Nucl. Med. Commun. 22, 1215\u20131221 (2001).","journal-title":"Nucl. Med. Commun."},{"key":"684_CR80","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1007\/s002590000342","volume":"27","author":"H Vilkman","year":"2000","unstructured":"Vilkman, H. et al. Measurement of extrastriatal D 2-like receptor binding with [11 C] FLB 457\u2013a test-retest analysis. Eur. J. Nucl. Med. 27, 1666\u20131673 (2000).","journal-title":"Eur. J. Nucl. Med."},{"key":"684_CR81","doi-asserted-by":"publisher","first-page":"e76905","DOI":"10.1371\/journal.pone.0076905","volume":"8","author":"R Narendran","year":"2013","unstructured":"Narendran, R., Himes, M. & Mason, N. S. Reproducibility of post-amphetamine [11C] FLB 457 binding to cortical D2\/3 receptors. PLoS One 8, e76905 (2013).","journal-title":"PLoS One"},{"key":"684_CR82","first-page":"916198","volume":"2012","author":"S Ochoa","year":"2012","unstructured":"Ochoa, S., Usall, J., Cobo, J., Labad, X. & Kulkarni, J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr. Res Treat. 2012, 916198 (2012).","journal-title":"Schizophr. Res Treat."},{"key":"684_CR83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/ajmg.b.32159","volume":"162B","author":"JM Goldstein","year":"2013","unstructured":"Goldstein, J. M., Cherkerzian, S., Tsuang, M. T. & Petryshen, T. L. Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am. J. Med Genet B Neuropsychiatr. Genet 162B, 698\u2013710 (2013).","journal-title":"Am. J. Med Genet B Neuropsychiatr. Genet"},{"key":"684_CR84","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/schbul\/sbm120","volume":"34","author":"JA Frazier","year":"2008","unstructured":"Frazier, J. A. et al. Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr. Bull. 34, 37\u201346 (2008).","journal-title":"Schizophr. Bull."},{"key":"684_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neubiorev.2015.10.013","volume":"67","author":"A Mendrek","year":"2016","unstructured":"Mendrek, A. & Mancini-Marie, A. Sex\/gender differences in the brain and cognition in schizophrenia. Neurosci. Biobehav Rev. 67, 57\u201378 (2016).","journal-title":"Neurosci. Biobehav Rev."},{"key":"684_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbr.2014.11.045","volume":"281","author":"C Gurvich","year":"2015","unstructured":"Gurvich, C. & Rossell, S. L. Dopamine and cognitive control: sex-by-genotype interactions influence the capacity to switch attention. Behav. Brain Res 281, 96\u2013101 (2015).","journal-title":"Behav. Brain Res"},{"key":"684_CR87","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1176\/ajp.155.6.768","volume":"155","author":"T Pohjalainen","year":"1998","unstructured":"Pohjalainen, T., Rinne, J. O., Nagren, K., Syvalahti, E. & Hietala, J. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am. J. Psychiatry 155, 768\u2013773 (1998).","journal-title":"Am. J. Psychiatry"},{"key":"684_CR88","doi-asserted-by":"publisher","unstructured":"Williams, O. O. F., Coppolino, M., George, S. R. & Perreault, M. L. Sex differences in dopamine receptors and relevance to neuropsychiatric disorders. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci11091199 (2021).","DOI":"10.3390\/brainsci11091199"},{"key":"684_CR89","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fnbeh.2014.00071","volume":"8","author":"SC Godar","year":"2014","unstructured":"Godar, S. C. & Bortolato, M. Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission. Front Behav. Neurosci. 8, 71 (2014).","journal-title":"Front Behav. Neurosci."},{"key":"684_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J","volume":"30","author":"Y Wang","year":"1998","unstructured":"Wang, Y. et al. Age-dependent decline of dopamine D1 receptors in human brain: A PET study. Synapse 30, 56\u201361 (1998).","journal-title":"Synapse"},{"key":"684_CR91","doi-asserted-by":"publisher","first-page":"113107","DOI":"10.1016\/j.celrep.2023.113107","volume":"42","author":"J Johansson","year":"2023","unstructured":"Johansson, J. et al. Biphasic patterns of age-related differences in dopamine D1 receptors across the adult lifespan. Cell Rep. 42, 113107 (2023).","journal-title":"Cell Rep."},{"key":"684_CR92","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/j.neurobiolaging.2009.10.018","volume":"32","author":"L Backman","year":"2011","unstructured":"Backman, L. et al. Dopamine D(1) receptors and age differences in brain activation during working memory. Neurobiol. Aging 32, 1849\u20131856 (2011).","journal-title":"Neurobiol. Aging"},{"key":"684_CR93","doi-asserted-by":"publisher","unstructured":"Sun, L. et al. Population-specific brain charts reveal Chinese-Western differences in neurodevelopmental trajectories. bioRxiv, https:\/\/doi.org\/10.1101\/2025.06.17.659820 (2025).","DOI":"10.1101\/2025.06.17.659820"},{"key":"684_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-022-01485-y","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. Publication bias impacts on effect size, statistical power, and magnitude (Type M) and sign (Type S) errors in ecology and evolutionary biology. BMC Biol. 21, 71 (2023).","journal-title":"BMC Biol."},{"key":"684_CR95","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.neuroimage.2008.12.039","volume":"45","author":"G Salimi-Khorshidi","year":"2009","unstructured":"Salimi-Khorshidi, G., Smith, S. M., Keltner, J. R., Wager, T. D. & Nichols, T. E. Meta-analysis of neuroimaging data: a comparison of image-based and coordinate-based pooling of studies. Neuroimage 45, 810\u2013823 (2009).","journal-title":"Neuroimage"},{"key":"684_CR96","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","journal-title":"BMJ"},{"key":"684_CR97","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0065-2660(07)00413-0","volume":"60","author":"TA Trikalinos","year":"2008","unstructured":"Trikalinos, T. A., Salanti, G., Zintzaras, E. & Ioannidis, J. P. Meta-analysis methods. Adv. Genet 60, 311\u2013334 (2008).","journal-title":"Adv. Genet"},{"key":"684_CR98","unstructured":"Raudenbush, S. Analysing effect sizes: random effects models. In: Cooper, H.; Hedges, L. V.;Valentine, J. C., editors. The handbook of research synthesis and meta-analysis. 2nd ed.. Russell Sage Foundation; New York, NY: 2009. 295-315."},{"key":"684_CR99","doi-asserted-by":"crossref","unstructured":"Schwarzer G., C. J. Carpenter, R\u00fccker G. Meta-Analysis with R. R. 2015; 217\u2013236.","DOI":"10.1007\/978-3-319-21416-0_9"},{"key":"684_CR100","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ (Clin. Res. ed.) 327, 557\u2013560 (2003).","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"684_CR101","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin. Res. ed.) 315, 629\u2013634 (1997).","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"684_CR102","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.euroneuro.2012.11.004","volume":"23","author":"S Leucht","year":"2013","unstructured":"Leucht, S., Rothe, P., Davis, J. M. & Engel, R. R. Equipercentile linking of the BPRS and the PANSS. Eur. Neuropsychopharmacol. 23, 956\u2013959 (2013).","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00684-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:04:04Z","timestamp":1763733844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41537-025-00684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1038\/s41537-025-00684-0","relation":{},"ISSN":["2754-6993"],"issn-type":[{"value":"2754-6993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}